Fekade Bruck Sime (F B Sime, Fekade B Sime, Fekade Sime)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 39

Top Topics

Escherichia Coli

Traumatic Brain Injury

Multidrug Resistant

Cerebrospinal Fluid

Top Venues

The Journal of antimicrobial chemotherapy

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

JAC-antimicrobial resistance

This page only lists publications with an associated author ORCID identifier.

Publications

Getnet M Assefa, Jason Alexander Roberts, Solomon A Mohammed, Fekade Bruck Sime
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Getnet M Assefa, Jason Alexander Roberts, Solomon A Mohammed, Fekade Bruck Sime
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Getnet M Assefa, Jason Alexander Roberts, Solomon A Mohammed, Fekade Bruck Sime
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. The Journal of antimicrobial chemotherapy (2024)
Zenaw T Wolie, Jason Alexander Roberts, Mark Gilchrist, Kate L McCarthy, Fekade Bruck Sime
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review. The Journal of antimicrobial chemotherapy 79 (9) (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Zenaw T Wolie, Jason Alexander Roberts, Mark Gilchrist, Kate L McCarthy, Fekade Bruck Sime
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review. The Journal of antimicrobial chemotherapy (2024)
Saiyuri Naicker, Jason Alexander Roberts, Hayoung Won, Steven C Wallis, Sean Unwin, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Fekade Bruck Sime
Evaluation of the stability of ceftazidime/avibactam in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy utilizing a national stability protocol framework. JAC-antimicrobial resistance 6 (2) (2024)
Getnet M Assefa, Jason Alexander Roberts, Solomon A Mohammed, Fekade Bruck Sime
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Getnet M Assefa, Jason Alexander Roberts, Solomon A Mohammed, Fekade Bruck Sime
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Getnet M Assefa, Jason Alexander Roberts, Solomon A Mohammed, Fekade Bruck Sime
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review. The Journal of antimicrobial chemotherapy 79 (5) (2024)
Chandra Datta Sumi, Jason Alexander Roberts, Fekade Bruck Sime
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' response. The Journal of antimicrobial chemotherapy (2023)
Chandra Datta Sumi, Jason Alexander Roberts, Fekade Bruck Sime
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Klebsiella pneumoniae-authors' response. The Journal of antimicrobial chemotherapy 78 (3) (2023)
Fekade Bruck Sime, Steven Wallis, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Jason Roberts, null null
Evaluation of the stability of aciclovir in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy. European journal of hospital pharmacy : science and practice (2023)
Srinivas Sulugodu Ramachandra, Fekade Bruck Sime, Saiyuri Naicker, Pingping Han, Ryan S B Lee, Steven C Wallis, Jason Alexander Roberts, Sašo Ivanovski
An in vitro dynamic bioreactor model for evaluating antimicrobial effectiveness on periodontal polymicrobial biofilms: a proof-of-concept study. Journal of periodontology (2023)
Mikaela M Walker, Jason Alexander Roberts, Benjamin A Rogers, Patrick N A Harris, Fekade Bruck Sime
Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Natalija Karabasevic, Jason Alexander Roberts, Luke Stronach, Saiyuri Naicker, Steven C Wallis, Fredrik Sjövall, Fekade Bruck Sime
Use of the Hollow-Fiber Infection Model to Measure the Effect of Combination Therapy of Septic Shock Exposures of Meropenem and Ciprofloxacin against Intermediate and Resistant Pseudomonas aeruginosa Clinical Isolates. Antimicrobial agents and chemotherapy 66 (5) (2022)
Kamrul Islam, Fekade Bruck Sime, Steven C Wallis, Michelle J Bauer, Saiyuri Naicker, Hayoung Won, Hosam M Zowawi, Md Abu Choudhury, Tahmina Shirin, Zakir H Habib, Patrick N A Harris, Meerjady S Flora, Jason Alexander Roberts
Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model. Antimicrobial agents and chemotherapy 66 (9) (2022)
Minyon L Avent, Kate L McCarthy, Fekade Bruck Sime, Saiyuri Naicker, Aaron J Heffernan, Steven C Wallis, David L Paterson, Jason Alexander Roberts
Evaluating Mono- and Combination Therapy of Meropenem and Amikacin against Pseudomonas aeruginosa Bacteremia in the Hollow-Fiber Infection Model. Microbiology spectrum 10 (3) (2022)
Kamrul Islam, Fekade Bruck Sime, Steven C Wallis, Michelle J Bauer, Brian M Forde, Patrick N A Harris, Tahmina Shirin, Zakir H Habib, Meerjady S Flora, Jason Alexander Roberts
Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model. The Journal of antimicrobial chemotherapy 77 (9) (2022)
Aaron J Heffernan, Fekade Bruck Sime, Nilesh Kumta, Steven C Wallis, Brett McWhinney, Jacobus Ungerer, Gloria Wong, Gavin M Joynt, Jeffrey Lipman, Jason Alexander Roberts
Multicenter Population Pharmacokinetic Study of Unbound Ceftriaxone in Critically Ill Patients. Antimicrobial agents and chemotherapy 66 (6) (2022)
Fekade Bruck Sime, Steven Wallis, Conor Jamieson, Tim Hills, Mark Gilchrist, Mark Santillo, R Andrew Seaton, Felicity Drummond, Jason Roberts, null null
Evaluation of the stability of temocillin in elastomeric infusion devices used for outpatient parenteral antimicrobial therapy in accordance with the requirements of the UK NHS Yellow Cover Document. European journal of hospital pharmacy : science and practice (2022)
Chandra Datta Sumi, Aaron J Heffernan, Saiyuri Naicker, Kyra Cottrell, Steven C Wallis, Jeffrey Lipman, Patrick N A Harris, Fekade Bruck Sime, Jason Alexander Roberts
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates. The Journal of antimicrobial chemotherapy 77 (11) (2022)
Mikaela M Walker, Jason Alexander Roberts, Benjamin A Rogers, Patrick N A Harris, Fekade Bruck Sime
Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Sazlyna Mohd Sazlly Lim, Aaron Heffernan, Saiyuri Naicker, Steven Wallis, Jason Alexander Roberts, Fekade Bruck Sime
Evaluation of Fosfomycin-Sulbactam Combination Therapy against Carbapenem-Resistant Acinetobacter baumannii Isolates in a Hollow-Fibre Infection Model. Antibiotics (Basel, Switzerland) 11 (11) (2022)
Sazlyna Mohd Sazlly Lim, Aaron J Heffernan, Hosam M Zowawi, Jason A Roberts, Fekade Bruck Sime
Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 40 (9) (2021)
Mohammad H Alshaer, Sylvain Goutelle, Barbara A Santevecchi, Bethany R Shoulders, Veena Venugopalan, Kartikeya Cherabuddi, Jiajun Liu, Patrick J Kiel, Jason Alexander Roberts, Fekade Bruck Sime, Marc H Scheetz, Michael N Neely, Charles A Peloquin
Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics. Antimicrobial agents and chemotherapy 66 (2) (2021)
Aaron Heffernan, Jowana Alawie, Steven C Wallis, Saiyuri Naicker, Santosh Adiraju, Jason Alexander Roberts, Fekade Bruck Sime
Pharmacodynamic Evaluation of a Single Dose versus a 24-Hour Course of Multiple Doses of Cefazolin for Surgical Prophylaxis. Antibiotics (Basel, Switzerland) 10 (5) (2021)
Kamrul Islam, Aaron J Heffernan, Saiyuri Naicker, Andrew Henderson, Mohammed Abul Hassan Chowdhury, Jason A Roberts, Fekade Bruck Sime
Epidemiology of extended-spectrum β-lactamase and metallo-β-lactamase-producing Escherichia coli in South Asia. Future microbiology 16 (2021)
Fekade Bruck Sime, Jason A Roberts, Rosalind L Jeffree, Saurabh Pandey, Santosh Adiraju, Amelia Livermore, Jenie Butler, Suzanne L Parker, Steven C Wallis, Jeffrey Lipman, Menino Osbert Cotta
Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance. Clinical pharmacokinetics 60 (5) (2021)
Jiajun Liu, Michael Noel Neely, Jeffrey Lipman, Fekade Bruck Sime, Jason Alexander Roberts, Patrick J Kiel, Sean N Avedissian, Nathaniel James Rhodes, Marc H Scheetz
Development of Population and Bayesian Models for Applied Use in Patients Receiving Cefepime. Clinical pharmacokinetics 59 (8) (2021)
Chandra Datta Sumi, Aaron J Heffernan, Jeffrey Lipman, Jason Alexander Roberts, Fekade Bruck Sime
What Antibiotic Exposures Are Required to Suppress the Emergence of Resistance for Gram-Negative Bacteria? A Systematic Review. Clinical pharmacokinetics 58 (11) (2020)
Aaron J Heffernan, Fekade Bruck Sime, Derek S Sarovich, Michael Neely, Yarmarly Guerra-Valero, Saiyuri Naicker, Kyra Cottrell, Patrick N A Harris, Katherine T Andrews, David Ellwood, Steven C Wallis, Jeffrey Lipman, Keith Grimwood, Jason Alexander Roberts
Pharmacodynamic Evaluation of Plasma and Epithelial Lining Fluid Exposures of Amikacin against Pseudomonas aeruginosa in a Dynamic In Vitro Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 64 (9) (2020)
Fekade Bruck Sime, Melissa Lassig-Smith, Therese Starr, Janine Stuart, Saurabh Pandey, Suzanne L Parker, Steven C Wallis, Jeffrey Lipman, Jason Alexander Roberts
Cerebrospinal Fluid Penetration of Ceftolozane-Tazobactam in Critically Ill Patients with an Indwelling External Ventricular Drain. Antimicrobial agents and chemotherapy 65 (1) (2020)
Sazlyna Mohd Sazlly Lim, Mahipal Sinnollareddy, Fekade Bruck Sime
Challenges in Antifungal Therapy in Diabetes Mellitus. Journal of clinical medicine 9 (9) (2020)
Fekade Bruck Sime, Melissa Lassig-Smith, Therese Starr, Janine Stuart, Saurabh Pandey, Suzanne L Parker, Steven C Wallis, Jeffrey Lipman, Jason Alexander Roberts
A Population Pharmacokinetic Model-Guided Evaluation of Ceftolozane-Tazobactam Dosing in Critically Ill Patients Undergoing Continuous Venovenous Hemodiafiltration. Antimicrobial agents and chemotherapy 64 (1) (2019)
A J Heffernan, A Germano, Fekade Bruck Sime, Jason A Roberts, E Kimura
Vancomycin population pharmacokinetics for adult patients with sepsis or septic shock: are current dosing regimens sufficient? European journal of clinical pharmacology 75 (9) (2019)
Fekade Bruck Sime, Melissa Lassig-Smith, Therese Starr, Janine Stuart, Saurabh Pandey, Suzanne L Parker, Steven C Wallis, Jeffrey Lipman, Jason Alexander Roberts
Population Pharmacokinetics of Unbound Ceftolozane and Tazobactam in Critically Ill Patients without Renal Dysfunction. Antimicrobial agents and chemotherapy 63 (10) (2019)